Concepedia

Weiyi Yang

WY

6

Publications

412

Citations

6

H-Index

1992

Active since

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

Howard Hughes Medical Institute

Johns Hopkins University

Weiyi Yang is an author at Shanghai Institute of Materia Medica specializing in drug discovery, medicinal chemistry, and medicine.

ORCID

Top concepts

Publications per year

1992–2024

6

Publications

6

BAP-135, a target for Bruton’s tyrosine kinase in response to B cell receptor engagement

Weiyi Yang, Stephen Desiderio · Proceedings of the National Academy of Sciences · 1997 · 177 citations

Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle

Ying Li, Feng Shan, Jinming Wu et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 90 citations

, , +9

[Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro].

Weichen Sun, Jia-Xian Han, Weiyi Yang et al. · PubMed · 1992 · 61 citations

, , +13

An SH3-binding Site Conserved in Bruton's Tyrosine Kinase and Related Tyrosine Kinases Mediates Specific Protein Interactions in Vitro and in Vivo

Weiyi Yang, Sami N. Malek, Stephen Desiderio · Journal of Biological Chemistry · 1995 · 54 citations · Full text

Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinoma

Shengtao Yuan, Xiongwen Zhang, Lijuan Lu et al. · Anti-Cancer Drugs · 2004 · 19 citations

, , +16

Rows per page

1–5 of 6